Sponsor Pipeline

Whitehawk Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07444814 Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug… Endometrial Cancer Recruiting
NCT07470853 A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced… PROC Recruiting
Disease Areas
Ovarian Cancer (2) Endometrial Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when Whitehawk Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free